We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neuroendocrine Differentiation in Prostatic Carcinomas: Histogenesis, Biology, Clinical Relevance, and Future Therapeutical Perspectives.
- Authors
Helpap; Köllermann; Oehler
- Abstract
Since the introduction of immunohistochemistry, there is an increasing interest in neuroendocrine (NE) differentiation in prostatic carcinomas. Focal NE differentiation in prostatic adenocarcinomas is a very frequent finding. It is subject of numerous studies, since a negative impact on prognosis and an important role in antiandrogen therapy failure are suspected. NE-differentiated small-cell carcinoma is a very rare tumor comprising 0.5–2% of all prostatic carcinomas. Nevertheless, although very rare, it is of clinical importance because it is one of the most aggressive tumors of the prostate with a very poor prognosis. This review is focused on actual concepts of histogen-esis, cell biology, clinical implications, and possible future therapeutic perspectives of these two tumor entities.
- Subjects
PROSTATE; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; BIOLOGY; TUMORS
- Publication
Urologia Internationalis, 1999, Vol 62, Issue 3, p133
- ISSN
0042-1138
- Publication type
Article
- DOI
10.1159/000030376